MALARIA,FALCIPARUM
Clinical trials for MALARIA,FALCIPARUM explained in plain language.
Never miss a new study
Get alerted when new MALARIA,FALCIPARUM trials appear
Sign up with your email to follow new studies for MALARIA,FALCIPARUM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Scientists test genetically weakened parasite as a malaria vaccine
⭐️ VACCINE ⭐️ Not yet recruitingThis is the first human study of a new malaria vaccine called PfSPZ-LARC2. It uses a live but genetically weakened malaria parasite that is designed to stop developing in the liver, preventing a full-blown infection. The main goals are to see if the vaccine is safe and tolerable …
Matched conditions: MALARIA,FALCIPARUM
Phase: PHASE1 • Sponsor: Sanaria Inc. • Aim: ⭐️ VACCINE ⭐️
Last updated Mar 30, 2026 14:29 UTC
-
Double defense: scientists test Vaccine-Drug combo to shield kids from malaria
Prevention Not yet recruitingThis study aims to find a better way to protect young children from malaria in Uganda. Researchers will test if giving children a new malaria vaccine (R21) along with preventive anti-malaria drugs works better than the vaccine alone. The study will enroll about 1,290 healthy infa…
Matched conditions: MALARIA,FALCIPARUM
Phase: PHASE4 • Sponsor: Stanford University • Aim: Prevention
Last updated Mar 31, 2026 12:12 UTC